Drug Development

Report: FDA will be pressed to do more with less

Published in Medical Letter on the CDC and FDA, February 15th, 2004

Pressure on the U.S. Food and Drug Administration (FDA) to maintain staff expertise will grow during 2004 as experienced agency staff retire or change jobs, and fewer new product applications limit funds available for new hires, according to the Tufts Center for the Study of Drug Development.

Adding to the FDA's burden is an expanded mission to implement counter-bioterrorism activities, review increasingly complex new product applications, and expand postmarket safety vigilance, the Tufts Center reported in its recently released "Outlook 2004" report on drug and biotech development trends.

"FDA personnel and resources will be under growing stress to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-02-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry